Arlington Capital Partners Announces the Acquisition of AVS Bio
Go back to Arlington Capital Partners Announces the Acquisition of AVS Bio| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 295.19 +3.74 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $291.45 | 52 Week High | $89.18 | |||
| Open | $291.78 | 52 Week Low | $65.70 | |||
| Day High | $298.18 | P/E | 137.30 | |||
| Day Low | $289.07 | EPS | $2.15 | |||
| Volume | 887,562 | |||||
